Asperosaponin VI therapy for Achilles tendinopathy in rabbits

doi:10.12307/2022.035

Abstract

Abstract: BACKGROUND: In recent years, tendonopathy occurs frequently as a chronic orthopedic injury, and there is still a lack of effective treatment as yet. Dipsacus L. has the effect of tonifying the liver and kidney, strengthening bones, and sustaining broken injuries.
OBJECTIVE: To analyze the repairing effect of Asperosaponin VI in a rabbit model of Achilles tendinopathy.
METHODS: Forty-eight rabbits were randomized into a normal control group (n=8), a model group (n=32), and a noral saline group (n=8). In the model group, the model of tendinopathy was made at the left calcaneus attachment injected with prostaglandin E2, and the models were then randomized into four subgroups, which were treated with 0, 10, 20, and 40 mg/kg Asperosaponin VI, respectively. Treatments in each group were conducted once a day for 4 consecutive weeks. The study protocol was approved by the Animal Ethics Committee of Chengdu Sport University with an approval No. [2020]21 on November 4, 2019.
RESULTS AND CONCLUSION: Compared with the normal control group, the expression of matrix metalloproteinase-1 was significantly higher in the model group (P < 0.05). Compared with the model group, the expression of matrix metalloproteinase-1 was significantly reduced in the 20 and 40 mg/kg groups (P < 0.05). The expression of tissue inhibitor of matrix metalloproteinases 1 was significantly higher in the model group than the normal control group (P < 0.05), while the expression of tissue inhibitor of matrix metalloproteinases 1 was significantly reduced in the 10, 20 and 40 mg/kg groups compared with the model group (P < 0.05). The expression of transforming growth factor-β1 was significantly higher in the 10, 20 and 40 mg/kg groups compared with the model group (P < 0.05). The expression of plasminogen activator inhibitor 1 was significantly higher in the 40 mg/kg group than the model group (P < 0.05). Tendon fibers in the 40 mg/kg group were intact and arranged orderly, which were similar to normal tendon tissue. Therefore, Asperosaponin VI can inhibit vicious cycle of degeneration of collagen in the extracellular matrix, induce the proliferation of tenocytes and promote the healing. It may be a potential drug for the treatment of tendinopathy.

Key words: Asperosaponin VI, tendinopathy, healing, collagen, extracellular matrix, tenocyte, proliferation, fibrosis

CLC Number:

Wang Kun, He Benxiang. Asperosaponin VI therapy for Achilles tendinopathy in rabbits[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(2): 211-217.

Figures/Tables 4

References

[1] NOURISSAT G, BERENBAUM F, DUPREZ D. Tendon injury: from biology to tendon repair. Nat Rev Rheumatol. 2015;11(4):223-233.
[2] RADOVANOVIĆ G, WOLFARTH B, LEGERLOTZ K. Interleukin‐6 levels drop after a 12 week long physiotherapeutic intervention in patients with Achilles tendinopathy—a pilot study. Transl Sports Med. 2019;2: 233-239.
[3] WANG Y, HE G, GUO Y, et al. Exosomes from tendon stem cells promote injury tendon healing through balancing synthesis and degradation of the tendon extracellular matrix. J Cell Mol Med. 2019;23(8):5475-5485.
[4] KHAN MR, SMITH RK, DAVID F, et al. Evaluation of the Effects of Synovial Multipotent Cells on Deep Digital Flexor Tendon Repair in a Large Animal Model of Intra-Synovial Tendinopathy. J Orthop Res. 2020; 38(1):128-138.
[5] WANG Y, HE G, TANG H, et al. Aspirin inhibits inflammation and scar formation in the injury tendon healing through regulating JNK/STAT-3 signalling pathway. Cell Prolif. 2019;52(4):e12650.
[6] ALVES C, MENDES D, MARQUES FB. Fluoroquinolones and the risk of tendon injury: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2019;75(10):1431-1443.
[7] TEIXEIRA PAG, JAQUET P, BAKOUR O, et al. CT arthrography of the intra-articular long head of biceps tendon: Diagnostic performance outside the labral-bicipital complex. Diagn Interv Imaging. 2019;100(7-8): 437-444.
[8] ZAMZAM M, EL YASAKI A, EL GARABAWY N, et al. Shockwave therapy versus local steroid injection in chronic supraspinatus tendinopathy. Egypt Rheumatol Rehabil. 2019;46:141-147.
[9] DAN MJ, WALSH WR, CROSS MJ, et al. Treatment of patella tendinopathy by distalising tibial tubercle osteotomy. BMJ Case Rep. 2019;12(7):e229209.
[10] BAAR K. Stress Relaxation and Targeted Nutrition to Treat Patellar Tendinopathy. Int J Sport Nutr Exerc Metab. 2019;29(4):453-457.
[11] NIE G, WEN X, LIANG X, et al. Additional evidence supports association of common genetic variants in MMP3 and TIMP2 with increased risk of chronic Achilles tendinopathy susceptibility. J Sci Med Sport. 2019;22(10):1074-1078.
[12] LEE SY, KIM W, LIM C, et al. Treatment of Lateral Epicondylosis by Using Allogeneic Adipose-Derived Mesenchymal Stem Cells: A Pilot Study. Stem Cells. 2015;33(10):2995-3005.
[13] RUI YF, LUI PP, LI G, et al. Isolation and characterization of multipotent rat tendon-derived stem cells. Tissue Eng Part A. 2010;16(5):1549-1558.
[14] ARNSDORF EJ, TUMMALA P, JACOBS CR. Non-canonical Wnt signaling and N-cadherin related beta-catenin signaling play a role in mechanically induced osteogenic cell fate. PLoS One. 2009;4(4):e5388.
[15] GURTNER GC, WERNER S, BARRANDON Y, et al. Wound repair and regeneration. Nature. 2008;453(7193):314-321.
[16] LIU ZG, ZHANG R, LI C, et al. The osteoprotective effect of Radix Dipsaci extract in ovariectomized rats. J Ethnopharmacol. 2009;123(1):74-81.
[17] JUNG HW, JUNG JK, SON KH, et al. Inhibitory effects of the root extract of Dipsacus asperoides C.Y. Cheng et al T.M.Ai on collagen-induced arthritis in mice. J Ethnopharmacol. 2012;139(1):98-103.
[18] Wong RW, Rabie AB, Hägg EU. The effect of crude extract from Radix Dipsaci on bone in mice. Phytother Res. 2007;21(6):596-598.
[19] HUNG TM, NA M, THUONG PT, et al. Antioxidant activity of caffeoyl quinic acid derivatives from the roots of Dipsacus asper Wall. J Ethnopharmacol. 2006;108(2):188-192.
[20] KE K, LI Q, YANG X, et al. Asperosaponin VI promotes bone marrow stromal cell osteogenic differentiation through the PI3K/AKT signaling pathway in an osteoporosis model. Sci Rep. 2016;6:35233.
[21] LOISELLE AE, YUKATA K, GEARY MB, et al. Development of antisense oligonucleotide (ASO) technology against Tgf-β signaling to prevent scarring during flexor tendon repair. J Orthop Res. 2015;33(6):859-866.
[22] QIN W, LIN ZM, DENG R, et al. p38a MAPK is involved in BMP-2-induced odontoblastic differentiation of human dental pulp cells. Int Endod J. 2012;45(3):224-233.
[23] 秦川.实验动物学[M].北京:人民卫生出版社,2010.
[24] KHAN MH, LI Z, WANG JH. Repeated exposure of tendon to prostaglandin-E2 leads to localized tendon degeneration. Clin J Sport Med. 2005;15(1):27-33.
[25] 陈磊.富血小板血浆诱导肌键干细胞增殖分化对肌键微损伤修复的作用[D].重庆:第三军医大学,2012.
[26] TSUZAKI M, GUYTON G, GARRETT W, et al. IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J Orthop Res. 2003;21(2):256-264.
[27] 史晓伟,龙丽娟,沈勇伟,等,末端病大鼠跟腱病超微结构、胶原、MMP-1及TIMP1的研究[J].中国运动医学杂志,2014,33(9):902-906.
[28] YANG S, ZHANG W, XUAN LL, et al. Akebia Saponin D inhibits the formation of atherosclerosis in ApoE-/- mice by attenuating oxidative stress-induced apoptosis in endothelial cells. Atherosclerosis. 2019; 285:23-30.
[29] TSUJIMOTO Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol. 2003;195(2):158-167.
[30] WANG CG, LOU YT, TONG MJ, et al. Asperosaponin VI promotes angiogenesis and accelerates wound healing in rats via up-regulating HIF-1α/VEGF signaling. Acta Pharmacol Sin. 2018;39(3):393-404.
[31] KE K, LI Q, YANG X, et al. Asperosaponin VI promotes bone marrow stromal cell osteogenic differentiation through the PI3K/AKT signaling pathway in an osteoporosis model. Sci Rep. 2016;6:35233.
[32] NIU Y, LI Y, HUANG H, et al. Asperosaponin VI, a saponin component from Dipsacus asper wall, induces osteoblast differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway. Phytother Res. 2011;25(11):1700-1706.
[33] BI F, SHI Z, JIANG S, et al. Intermittently administered parathyroid hormone [1-34] promotes tendon-bone healing in a rat model. Int J Mol Sci. 2014;15(10):17366-17379.
[34] PARK JY, PARK SD, KOH YJ, et al. Aqueous extract of Dipsacus asperoides suppresses lipopolysaccharide-stimulated inflammatory responses by inhibiting the ERK1/2 signaling pathway in RAW 264.7 macrophages. J Ethnopharmacol. 2019;231:253-261.
[35] MAJEWSKI M, PORTER RM, BETZ OB, et al. Improvement of tendon repair using muscle grafts transduced with TGF-β1 cDNA. Eur Cell Mater. 2012;23:94-102.
[36] OKAMOTO S, TOHYAMA H, KONDO E, et al. Ex vivo supplementation of TGF-beta1 enhances the fibrous tissue regeneration effect of synovium-derived fibroblast transplantation in a tendon defect: a biomechanical study. Knee Surg Sports Traumatol Arthrosc. 2008;16(3):333-339.
[37] YAMAZAKI S, YASUDA K, TOMITA F, et al. The effect of transforming growth factor-beta1 on intraosseous healing of flexor tendon autograft replacement of anterior cruciate ligament in dogs. Arthroscopy. 2005; 21(9):1034-1041.
[38] PREMDAS J, TANG JB, WARNER JP, et al. The presence of smooth muscle actin in fibroblasts in the torn human rotator cuff. J Orthop Res. 2001;19(2):221-228.
[39] 王尉,何恢绪,彭心昭,等.转化生长因子-β1对肌腱细胞DNA及胶原合成的影响[J].中华创伤杂志,2001,17(10):618-619.
[40] MICHEL K, ROTH S, TRAUTWEIN C, et al. Analysis of the expression pattern of the latent transforming growth factor beta binding protein isoforms in normal and diseased human liver reveals a new splice variant missing the proteinase-sensitive hinge region. Hepatology. 1998;27(6):1592-1599.
[41] 耿震,王震,周海洋.富血小板血浆对肌健愈合影响的实验研究[J].中国修复重建外科杂志,2011,25(3):344-348.
[42 ] 史晓伟,周学兰.TGF-β1多效性与肌腱修复研究进展[J].中国运动医学杂志,2016,35(6):588-591.
[43] FAVATA M, BEREDJIKLIAN PK, ZGONIS MH, et al. Regenerative properties of fetal sheep tendon are not adversely affected by transplantation into an adult environment. J Orthop Res. 2006;24(11):2124-2132.
[44] CHEN Q, LU H, YANG H. Chitosan inhibits fibroblasts growth in Achilles tendon via TGF-β1/Smad3 pathway by miR-29b. Int J Clin Exp Pathol. 2014;7(12):8462-8470.
[45] FU SC, WONG YP, CHEUK YC, et al. TGF-beta1 reverses the effects of matrix anchorage on the gene expression of decorin and procollagen type I in tendon fibroblasts. Clin Orthop Relat Res. 2005;(431):226-232.
[46] MAUVIEL A, CHUNG KY, AGARWAL A, et al. Cell-specific induction of distinct oncogenes of the Jun family is responsible for differential regulation of collagenase gene expression by transforming growth factor-beta in fibroblasts and keratinocytes. J Biol Chem. 1996;271(18): 10917-10923.
[47] MARTIN J, YUNG S, ROBSON RL, et al. Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells. Perit Dial Int. 2000;20(5):524-533.
[48] MA C, CHEGINI N. Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-beta1. Mol Hum Reprod. 1999;5(10):950-954.
[49] FARHAT YM, AL-MALIKI AA, CHEN T, et al. Gene expression analysis of the pleiotropic effects of TGF-β1 in an in vitro model of flexor tendon healing. PLoS One. 2012;7(12):e51411.
[50] FARHAT YM, AL-MALIKI AA, EASA A, et al. TGF-β1 Suppresses Plasmin and MMP Activity in Flexor Tendon Cells via PAI-1: Implications for Scarless Flexor Tendon Repair. J Cell Physiol. 2015;230(2):318-326.
[51] YANG Y, YANG S, CHEN M, et al. Compound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts. J Ethnopharmacol. 2008;118(2):264-270.
[52] TUAN TL, WU H, HUANG EY, et al. Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures. Am J Pathol. 2003;162(5): 1579-1589.
[53] TITAN AL, LONGAKER MT. A fine balance in tendon healing. Nat Cell Biol. 2019;21(12):1466-1467.
[54] SPIESZ EM, THORPE CT, CHAUDHRY S, et al. Tendon extracellular matrix damage, degradation and inflammation in response to in vitro overload exercise. J Orthop Res. 2015;33(6):889-897.